Clinical Laserthermia Systems AB Class B (CLS.B) Stock Statistics & Valuation Metrics

Clinical Laserthermia Systems AB Class B has a market cap or net worth of SEK 85.39M. The enterprise value is SEK 100.00M.

Market Cap

SEK 85.39M

Enterprise Value

SEK 100.00M

Clinical Laserthermia Systems AB Class B has 48,513,240 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

48,513,240

Owned by Insiders

―

Owned by Institutions

―

Clinical Laserthermia Systems AB Class B’s return on equity (ROE) is -0.60 and return on invested capital (ROIC) is -43.61%.

Return on Equity (ROE)

-0.60

Return on Assets (ROA)

-0.54

Return on Invested Capital (ROIC)

-43.61%

Return on Capital Employed (ROCE)

-0.44

Revenue Per Employee

1.35M

Profits Per Employee

-3.20M

Employee Count

13

Asset Turnover

0.23

Inventory Turnover

3.66

The current PE Ratio of Clinical Laserthermia Systems AB Class B is -1.30. Clinical Laserthermia Systems AB Class B’s PEG ratio is -0.02.

PE Ratio

-1.30

PS Ratio

4.41

PB Ratio

1.15

Price to FCF

-1.71

Price to Operating Cash Flow

-2.19

PEG Ratio

-0.02

In the last 12 months, Clinical Laserthermia Systems AB Class B had revenue of 17.49M and earned -41.61M in profits. Earnings per share was -1.61.

Revenue

17.49M

Gross Profit

-29.00M

Operating Income

-29.00M

Pretax Income

-42.05M

Net Income

-41.61M

EBITDA

-26.41M

Earnings Per Share (EPS)

-1.61

In the last 12 months, operating cash flow was -25.04M and capital expenditures -7.31M, giving a free cash flow of -32.35M billion.

Operating Cash Flow

-25.04M

Free Cash Flow

-32.35M

Free Cash Flow per Share

-1.04

Clinical Laserthermia Systems AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-58.37%

Earnings Yield

-72.00%

Beta

0.39

52-Week Price Change

-75.97%

50-Day Moving Average

1.83

200-Day Moving Average

3.74

Relative Strength Index (RSI)

44.80

Average Volume (3m)

65.19K

Clinical Laserthermia Systems AB Class B upcoming earnings date is Nov 13, 2026, TBA (Not Confirmed).

Last Earnings Date

Jul 17, 2026

Next Earnings Date

Nov 13, 2026

Ex-Dividend Date

―

Clinical Laserthermia Systems AB Class B as a current ratio of 3.91, with Debt / Equity ratio of 0.00%

Current Ratio

3.91

Quick Ratio

2.64

Debt to Market Cap

0.00

Net Debt to EBITDA

0.82

Interest Coverage Ratio

-308.57

In the past 12 months, Clinical Laserthermia Systems AB Class B has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

Clinical Laserthermia Systems AB Class B EV to EBITDA ratio is -1.36, with an EV/FCF ratio of -1.59.

EV to Sales

4.10

EV to EBITDA

-1.36

EV to Free Cash Flow

-1.59

EV to Operating Cash Flow

-2.06

Clinical Laserthermia Systems AB Class B has SEK 3.87M in cash and marketable securities with SEK 0.00 in debt, giving a net cash position of SEK 3.87M billion.

Cash & Marketable Securities

SEK 3.87M

Total Debt

SEK 0.00

Net Cash

SEK 3.87M

Net Cash Per Share

SEK 0.08

Tangible Book Value Per Share

SEK 1.10

Gross margin is -32.65%, with operating margin of -329.87%, and net profit margin of -314.55%.

Gross Margin

-32.65%

Operating Margin

-329.87%

Pretax Margin

-317.97%

Net Profit Margin

-314.55%

EBITDA Margin

-302.23%

EBIT Margin

-323.33%

The average price target for Clinical Laserthermia Systems AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-47.42%

EPS Growth Forecast

44.01%

Smart Score

―

AI Score

43